Author:
Uttamsingh Vinita,Gallegos Richard,Liu Julie F.,Harbeson Scott L.,Bridson Gary W.,Cheng Changfu,Wells David S.,Graham Philip B.,Zelle Robert,Tung Roger
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference32 articles.
1. CYP2D6 Inhibition by Fluoxetine, Paroxetine, Sertraline, and Venlafaxine in a Crossover Study: Intraindividual Variability and Plasma Concentration Correlations
2. Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
3. Blagojevic N, Storr G, Allen JB, Hatanaka H, and Nakagawa H (1994) Treatment planning techniques for neutron capture therapy, in Proceedings of an international workshop on macro- and microdosimetry and treatment planning for neutron capture therapy, in Topics in Dosimetry & Treatment Planning for Neutron Capture Therapy (Zamenhof RG, Solares GR and Harling OK, eds); 1991 October 31–November 1; Massachusetts Institute of Technology. p 125, Advanced Medical Publishing, Inc., Madison, WI.
4. The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.
5. Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献